Come up with a name for your new list and we'll add to it:
Orca Therapeutics raised a round of funding on January 01, 2005. Investors include
Aglaia Biomedical Ventures.
Central to ORCA Therapeutics is the use of Oncolytic Replication Competent Agents (ORCA). These agents are typically derived from naturally occurring oncolytic viruses. Oncolytic viruses replicate sel…